Insider Trading activities at Iteos Therapeutics, Inc. (ITOS)

Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Iteos Therapeutics, Inc. (ITOS) since 2020 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Iteos Therapeutics, Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 1808865.

Total stock buying since 2020: $133,923,239.
Total stock sales since 2020: $226,100,036.
Total stock option exercises since 2020: $3,652,137.


19 insiders reported insider trading activities at Iteos Therapeutics, Inc. (ITOS):
Insider trading activities of Foley Todd
Insider trading activities of Biniszkiewicz Detlev
Insider trading activities of Ecor1 Capital, Llc
Insider trading activities of Lewis Joseph
Insider trading activities of Shah Rajeev M.
Insider trading activities of Call Matthew
Insider trading activities of Van Hauwermeiren Timothy
Insider trading activities of Mpm Bioventures 2018 Gp Llc
Insider trading activities of Lager Joanne Jenkins
Insider trading activities of Mcgrath Yvonne
Insider trading activities of Mpm Asset Management Investors Bv2018 Llc
Insider trading activities of Detheux Michel
Insider trading activities of Gall Matthew
Insider trading activities of Hallal David
Insider trading activities of Mva Investors, Llc
Insider trading activities of Oncology Impact Fund (cayman) Management L.p.
Insider trading activities of Davis Aaron I.
Insider trading activities of Ubs Oncology Impact Fund L.p.
Insider trading activities of Mpm Oncology Impact Management Gp Llc

Table 1. Yearly summary of insider stock purchases, sales, and option exercises at Iteos Therapeutics, Inc. (ITOS).
Insider Buying Insider Sales Option Exercises
Year Shares Value Shares Value Shares Value
2025 4,958,978 $38,686,391 2,668,407 $22,281,226 510,467 $2,195,004
2024 5,000 $38,635 0 $0 0 $0
2023 5,000 $41,849 350,000 $5,447,050 40,226 $118,666
2022 50,000 $1,640,919 2,971,592 $105,405,453 72,115 $345,920
2021 5,000 $130,445 3,027,020 $92,966,307 218,718 $992,547
2020 4,915,000 $93,385,000 0 $0 0 $0

Table 2. Monthly summary of insider trading at Iteos Therapeutics, Inc. (ITOS).
Trading Period Insider Buying Insider Sales Option Exercises
year-month Shares Value Shares Value Shares Value
2025-06 0 $0 376,094 $3,805,185 488,121 $2,098,917
2025-05 4,958,978 $38,686,391 2,292,313 $18,476,041 22,346 $96,087
2024-11 5,000 $38,635 0 $0 0 $0
2023-10 5,000 $41,849 0 $0 0 $0
2023-08 0 $0 350,000 $5,447,050 0 $0
2023-03 0 $0 0 $0 40,226 $118,666
2022-06 0 $0 29,615 $597,784 29,615 $113,125
2022-05 0 $0 763,000 $16,483,095 0 $0
2022-04 0 $0 286,500 $7,933,107 11,500 $48,645
2022-03 50,000 $1,640,919 607,138 $21,411,416 13,500 $57,450
2022-02 0 $0 18,000 $630,377 3,500 $15,050
2022-01 0 $0 1,267,339 $58,349,674 14,000 $111,650
2021-12 0 $0 475,188 $17,355,495 90,500 $355,398
2021-11 0 $0 556,915 $19,819,252 44,263 $322,874
2021-10 0 $0 565,641 $15,399,029 14,429 $88,882
2021-09 0 $0 1,297,780 $36,533,046 0 $0
2021-08 0 $0 23,248 $653,367 0 $0
2021-07 0 $0 0 $0 53,672 $158,332
2021-06 5,000 $130,445 15,854 $318,441 15,854 $67,061
2021-04 0 $0 92,394 $2,887,677 0 $0
2020-07 4,915,000 $93,385,000 0 $0 0 $0

Table 3. Detailed insider trading at Iteos Therapeutics, Inc. (ITOS)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2025-06-10 Detheux Michel (Chief Executive Officer) Sale 52,283 10.02 523,875
2025-06-10 Detheux Michel (Chief Executive Officer) Option Ex 164,310 4.30 706,533
2025-06-09 Detheux Michel (Chief Executive Officer) Sale 52,282 10.03 524,388
2025-06-09 Detheux Michel (Chief Executive Officer) Option Ex 52,282 4.30 224,812
2025-06-06 Detheux Michel (Chief Executive Officer) Sale 52,282 10.21 533,799
2025-06-06 Detheux Michel (Chief Executive Officer) Option Ex 52,282 4.30 224,812
2025-06-06 Hallal David Sale 38,228 10.24 391,454
2025-06-06 Hallal David Option Ex 38,228 4.30 164,380
2025-06-05 Detheux Michel (Chief Executive Officer) Sale 52,282 10.15 530,662
2025-06-05 Detheux Michel (Chief Executive Officer) Option Ex 52,282 4.30 224,812
2025-06-05 Hallal David Sale 38,227 10.15 388,004
2025-06-05 Hallal David Option Ex 38,227 4.30 164,376
2025-06-04 Detheux Michel (Chief Executive Officer) Sale 52,283 10.10 528,058
2025-06-04 Detheux Michel (Chief Executive Officer) Option Ex 52,283 4.30 224,816
2025-06-04 Hallal David Sale 38,227 10.07 384,945
2025-06-04 Hallal David Option Ex 38,227 4.30 164,376
2025-05-15 Ecor1 Capital, Llc Buy 3,300,000 8.00 26,400,000
2025-05-14 Ecor1 Capital, Llc Buy 1,658,978 7.41 12,286,391
2025-05-13 Mpm Bioventures 2018 Gp Llc Sale 630,191 8.06 5,079,339
2025-05-13 Van Hauwermeiren Timothy Option Ex 22,346 4.30 96,087
2025-05-13 Ubs Oncology Impact Fund L.p. Sale 1,031,931 8.06 8,317,363
2025-05-13 Foley Todd Sale 630,191 8.06 5,079,339
2024-11-19 Gall Matthew (Chief Financial Officer) Buy 5,000 7.73 38,635
2023-10-12 Gall Matthew (Chief Financial Officer) Buy 5,000 8.37 41,849
2023-08-23 Davis Aaron I. Sale 350,000 15.56 5,447,050
2023-03-28 Call Matthew (Chief Operating Officer) Option Ex 40,226 2.95 118,666
2022-06-09 Hallal David (Director) Sale 1,171 19.51 22,846
2022-06-09 Hallal David (Director) Option Ex 1,171 4.23 4,953
2022-06-08 Hallal David (Director) Sale 28,444 20.21 574,938
2022-06-08 Hallal David (Director) Option Ex 28,444 3.80 108,172
2022-05-11 Davis Aaron I. (Director) Sale 338,000 17.89 6,046,820
2022-05-10 Davis Aaron I. (Director) Sale 100,000 24.97 2,497,300
2022-05-09 Davis Aaron I. (Director) Sale 225,000 23.19 5,217,075
2022-05-02 Davis Aaron I. (Director) Sale 100,000 27.22 2,721,900
2022-04-29 Davis Aaron I. (Director) Sale 125,000 27.61 3,451,875
2022-04-28 Davis Aaron I. (Director) Sale 150,000 27.40 4,110,300
2022-04-18 Detheux Michel (Chief Executive Officer) Sale 11,500 32.26 370,932
2022-04-18 Detheux Michel (Chief Executive Officer) Option Ex 11,500 4.23 48,645
2022-03-23 Davis Aaron I. (Director) Buy 20,000 32.85 656,979
2022-03-22 Detheux Michel (Chief Executive Officer) Sale 18,437 34.82 641,976
2022-03-22 Davis Aaron I. (Director) Buy 30,000 32.80 983,940
2022-03-17 Lewis Joseph (10% Owner) Sale 575,201 35.25 20,275,835
2022-03-11 Lager Joanne Jenkins (Chief Medical Officer) Sale 3,500 36.01 126,035
2022-03-11 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 3,500 4.30 15,050
2022-03-01 Mcgrath Yvonne (Chief Scientific Officer) Sale 10,000 36.76 367,570
2022-03-01 Mcgrath Yvonne (Chief Scientific Officer) Option Ex 10,000 4.24 42,400
2022-02-23 Detheux Michel (Chief Executive Officer) Sale 14,500 34.81 504,745
2022-02-11 Lager Joanne Jenkins (Chief Medical Officer) Sale 3,500 35.90 125,632
2022-02-11 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 3,500 4.30 15,050
2022-01-25 Detheux Michel (Chief Executive Officer) Sale 14,500 35.83 519,535
2022-01-14 Lager Joanne Jenkins (Chief Medical Officer) Sale 3,500 39.41 137,952
2022-01-14 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 3,500 4.30 15,050
2022-01-05 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 18,135 42.03 762,214
2022-01-05 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 18,135 42.03 762,214
2022-01-05 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 30,347 42.03 1,275,484
2022-01-04 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 128,550 44.26 5,689,623
2022-01-04 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 128,550 44.26 5,689,623
2022-01-04 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 215,122 44.26 9,521,299
2022-01-04 Davis Aaron I. (Director) Sale 184,677 43.78 8,085,159
2022-01-03 Biniszkiewicz Detlev (Director) Sale 3,500 51.90 181,650
2022-01-03 Biniszkiewicz Detlev (Director) Option Ex 3,500 19.00 66,500
2022-01-03 Lager Joanne Jenkins (Chief Medical Officer) Sale 7,000 51.90 363,300
2022-01-03 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 7,000 4.30 30,100
2022-01-03 Davis Aaron I. (Director) Sale 515,323 49.22 25,361,621
2021-12-27 Gall Matthew (Chief Financial Officer) Sale 5,000 46.45 232,250
2021-12-22 Detheux Michel (Chief Executive Officer) Sale 16,163 44.80 724,183
2021-12-22 Detheux Michel (Chief Executive Officer) Option Ex 1,663 4.30 7,150
2021-12-21 Detheux Michel (Chief Executive Officer) Sale 19,226 44.60 857,575
2021-12-21 Detheux Michel (Chief Executive Officer) Option Ex 19,226 4.30 82,671
2021-12-20 Detheux Michel (Chief Executive Officer) Sale 9,111 43.94 400,337
2021-12-20 Detheux Michel (Chief Executive Officer) Option Ex 9,111 4.30 39,177
2021-12-20 Hallal David (Director) Sale 50,000 43.57 2,178,500
2021-12-20 Hallal David (Director) Option Ex 50,000 3.62 181,250
2021-12-17 Lager Joanne Jenkins (Chief Medical Officer) Sale 7,000 41.00 287,000
2021-12-17 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 7,000 4.30 30,100
2021-12-10 Lager Joanne Jenkins (Chief Medical Officer) Sale 3,500 34.50 120,750
2021-12-10 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 3,500 4.30 15,050
2021-12-07 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 19,456 33.63 654,305
2021-12-07 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 19,456 33.63 654,305
2021-12-07 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 32,558 33.63 1,094,925
2021-12-06 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 10,208 33.76 344,622
2021-12-06 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 10,208 33.76 344,622
2021-12-06 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 17,083 33.76 576,722
2021-12-03 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 20,167 35.46 715,121
2021-12-03 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 20,167 35.46 715,121
2021-12-03 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 33,749 35.46 1,196,739
2021-12-02 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 37,187 34.28 1,274,956
2021-12-02 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 37,187 34.28 1,274,956
2021-12-02 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 62,230 34.28 2,133,555
2021-12-01 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 12,395 34.59 428,743
2021-12-01 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 12,395 34.59 428,743
2021-12-01 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 20,742 34.59 717,465
2021-11-30 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 33,937 34.91 1,184,570
2021-11-30 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 33,937 34.91 1,184,570
2021-11-30 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 56,801 34.91 1,982,638
2021-11-29 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 10,371 34.91 362,103
2021-11-29 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 10,371 34.91 362,103
2021-11-29 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 17,356 34.91 605,984
2021-11-26 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 12,674 35.76 453,222
2021-11-26 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 12,674 35.76 453,222
2021-11-26 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 21,210 35.76 758,469
2021-11-24 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 36,337 36.09 1,311,402
2021-11-24 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 36,337 36.09 1,311,402
2021-11-24 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 60,808 36.09 2,194,560
2021-11-23 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 20,004 36.35 727,245
2021-11-23 Detheux Michel (Chief Executive Officer) Sale 14,500 36.08 523,160
2021-11-23 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 20,004 36.35 727,245
2021-11-23 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 33,476 36.35 1,217,019
2021-11-22 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 21,114 37.48 791,458
2021-11-22 Detheux Michel (Chief Executive Officer) Option Ex 16,263 12.45 202,474
2021-11-22 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 21,114 37.48 791,458
2021-11-22 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 35,333 37.48 1,324,457
2021-11-18 Lager Joanne Jenkins (Chief Medical Officer) Sale 28,000 34.50 966,000
2021-11-18 Lager Joanne Jenkins (Chief Medical Officer) Option Ex 28,000 4.30 120,400
2021-11-03 Detheux Michel (Chief Executive Officer) Sale 6,085 28.89 175,777
2021-11-02 Detheux Michel (Chief Executive Officer) Sale 14,391 28.41 408,920
2021-11-01 Detheux Michel (Chief Executive Officer) Sale 81 28.00 2,268
2021-10-21 Detheux Michel (Chief Executive Officer) Sale 196 28.00 5,488
2021-10-19 Detheux Michel (Chief Executive Officer) Sale 201 28.00 5,628
2021-10-18 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 6,167 27.14 167,372
2021-10-18 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 6,167 27.14 167,372
2021-10-18 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 10,320 27.14 280,084
2021-10-15 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 10,932 27.77 303,581
2021-10-15 Detheux Michel (Chief Executive Officer) Sale 1,635 28.01 45,796
2021-10-15 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 10,932 27.77 303,581
2021-10-15 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 18,295 27.77 508,052
2021-10-14 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 27,320 27.30 745,836
2021-10-14 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 27,320 27.30 745,836
2021-10-14 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 45,719 27.30 1,248,128
2021-10-13 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 20,929 27.13 567,803
2021-10-13 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 20,929 27.13 567,803
2021-10-13 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 35,023 27.13 950,173
2021-10-12 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 8,521 27.09 230,833
2021-10-12 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 8,521 27.09 230,833
2021-10-12 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 14,260 27.09 386,303
2021-10-11 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 48,812 27.24 1,329,638
2021-10-11 Gall Matthew (Chief Financial Officer) Option Ex 14,429 6.16 88,882
2021-10-11 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 48,812 27.24 1,329,638
2021-10-11 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 81,684 27.24 2,225,072
2021-10-08 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 2,032 27.01 54,884
2021-10-08 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 2,032 27.01 54,884
2021-10-08 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 3,400 27.01 91,834
2021-10-07 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 1,149 27.00 31,023
2021-10-07 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 1,149 27.00 31,023
2021-10-07 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 1,922 27.00 51,894
2021-10-04 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 20,711 27.06 560,439
2021-10-04 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 20,711 27.06 560,439
2021-10-04 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 34,659 27.06 937,872
2021-10-01 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 6,855 27.00 185,085
2021-10-01 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 6,855 27.00 185,085
2021-10-01 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 11,471 27.00 309,717
2021-09-30 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 2,292 27.00 61,884
2021-09-30 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 2,292 27.00 61,884
2021-09-30 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 3,836 27.00 103,572
2021-09-28 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 19,214 27.00 518,778
2021-09-28 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 19,214 27.00 518,778
2021-09-28 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 32,154 27.00 868,158
2021-09-27 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 11,625 27.09 314,921
2021-09-27 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 11,625 27.09 314,921
2021-09-27 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 19,455 27.09 527,035
2021-09-24 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 4,913 27.81 136,630
2021-09-24 Detheux Michel (Chief Executive Officer) Sale 1,089 28.02 30,511
2021-09-24 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 4,913 27.81 136,630
2021-09-24 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 8,221 27.81 228,626
2021-09-23 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 36,930 28.17 1,040,318
2021-09-23 Detheux Michel (Chief Executive Officer) Sale 5,322 28.16 149,862
2021-09-23 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 36,930 28.17 1,040,318
2021-09-23 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 61,800 28.17 1,740,906
2021-09-22 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 14,294 27.54 393,656
2021-09-22 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 14,294 27.54 393,656
2021-09-22 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 23,921 27.54 658,784
2021-09-21 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 19,635 27.47 539,373
2021-09-21 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 19,635 27.47 539,373
2021-09-21 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 32,858 27.47 902,609
2021-09-20 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 24,303 27.43 666,752
2021-09-20 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 24,303 27.43 666,752
2021-09-20 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 40,673 27.43 1,115,863
2021-09-17 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 45,698 28.82 1,317,016
2021-09-17 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 45,698 28.82 1,317,016
2021-09-17 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 76,473 28.82 2,203,951
2021-09-16 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 21,253 28.47 605,072
2021-09-16 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 21,253 28.47 605,072
2021-09-16 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 35,565 28.47 1,012,535
2021-09-15 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 24,104 27.97 674,188
2021-09-15 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 24,104 27.97 674,188
2021-09-15 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 40,336 27.97 1,128,197
2021-09-14 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 21,561 27.75 598,209
2021-09-14 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 21,561 27.75 598,209
2021-09-14 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 36,081 27.75 1,001,067
2021-09-13 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 21,384 27.64 591,053
2021-09-13 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 21,384 27.64 591,053
2021-09-13 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 35,785 27.64 989,097
2021-09-10 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 13,531 28.30 382,859
2021-09-10 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 13,531 28.30 382,859
2021-09-10 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 22,643 28.30 640,683
2021-09-09 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 22,725 28.97 658,343
2021-09-09 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 22,725 28.97 658,343
2021-09-09 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 38,028 28.97 1,101,671
2021-09-08 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 12,092 28.86 348,914
2021-09-08 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 12,092 28.86 348,914
2021-09-08 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 20,236 28.86 583,909
2021-09-07 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 30,474 29.18 889,231
2021-09-07 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 30,474 29.18 889,231
2021-09-07 Oncology Impact Fund (cayman) Management L.p. (10% Owner) Sale 50,996 29.18 1,488,063
2021-09-02 Detheux Michel (Chief Executive Officer) Sale 11,568 29.20 337,831
2021-09-01 Detheux Michel (Chief Executive Officer) Sale 8,684 28.30 245,722
2021-08-31 Detheux Michel (Chief Executive Officer) Sale 4,093 28.12 115,095
2021-08-30 Detheux Michel (Chief Executive Officer) Sale 2,322 28.01 65,039
2021-08-27 Detheux Michel (Chief Executive Officer) Sale 8,248 28.17 232,346
2021-08-25 Detheux Michel (Chief Executive Officer) Sale 861 28.00 24,108
2021-08-24 Detheux Michel (Chief Executive Officer) Sale 225 28.26 6,358
2021-08-23 Detheux Michel (Chief Executive Officer) Sale 7,499 28.06 210,421
2021-07-30 Call Matthew (Chief Operating Officer) Option Ex 53,672 2.95 158,332
2021-06-16 Gall Matthew (Chief Financial Officer) Buy 5,000 26.09 130,445
2021-06-08 Mcgrath Yvonne (VP, Research and Development) Sale 7,927 20.00 158,540
2021-06-08 Mcgrath Yvonne (VP, Research and Development) Option Ex 7,927 4.23 33,531
2021-06-02 Mcgrath Yvonne (VP, Research and Development) Sale 323 20.00 6,460
2021-06-02 Mcgrath Yvonne (VP, Research and Development) Option Ex 323 4.23 1,366
2021-06-01 Mcgrath Yvonne (VP, Research and Development) Sale 7,604 20.18 153,441
2021-06-01 Mcgrath Yvonne (VP, Research and Development) Option Ex 7,604 4.23 32,164
2021-04-09 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 119 29.99 3,568
2021-04-09 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 119 29.99 3,568
2021-04-08 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 19,304 30.76 593,791
2021-04-08 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 19,304 30.76 593,791
2021-04-08 Mpm Oncology Impact Management Gp Llc (10% Owner) Sale 32,304 30.76 993,671
2021-04-07 Mpm Bioventures 2018 Gp Llc (10% Owner) Sale 5,783 32.92 190,359
2021-04-07 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Sale 5,783 32.92 190,359
2021-04-07 Mpm Oncology Impact Management Gp Llc (10% Owner) Sale 9,678 32.92 318,570
2020-07-28 Mpm Bioventures 2018 Gp Llc (10% Owner) Buy 160,000 19.00 3,040,000
2020-07-28 Mpm Asset Management Investors Bv2018 Llc (10% Owner) Buy 160,000 19.00 3,040,000
2020-07-28 Oncology Impact Fund (cayman) Management L.p. (Other) Buy 320,000 19.00 6,080,000
2020-07-28 Shah Rajeev M. Buy 1,425,000 19.00 27,075,000
2020-07-28 Mva Investors, Llc (10% Owner) Buy 1,425,000 19.00 27,075,000
2020-07-28 Davis Aaron I. (Director) Buy 1,425,000 19.00 27,075,000

Insider trading activities including stock purchases, stock sales, and option exercises of ITOS listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Iteos Therapeutics, Inc. (symbol ITOS, CIK number 1808865) see the Securities and Exchange Commission (SEC) website.



©2023, insider-monitor.com. All rights reserved.